In Europe, lung cancer accounts
for around 20% of the total deaths due to cancer. With a 5-year survival rate
of 11.2% for men and 13.9% for women in 2014, lung cancer is the leading cause
of cancer related deaths in Europe. Majority of the lung cancer patients in
Europe were found to be suffering from Non-Small Cell Lung Cancer (NSCLC) in
2014, and the trend is anticipated to continue through 2020. Hence, with
increasing prevalence of NSCLC among European citizens, demand for NSCLC treatment
is forecast to grow at a robust pace over the next five years.
“Europe Non-Small Cell Lung Cancer Treatments
Market Opportunities, 2010 - 2020” report
studies the market size and share of various segments and sub-segments of the non- small cell lung cancer treatments market in
the Europe during the period 2010 - 2020. In the study, the market has been categorized
into four broader segments that include Chemotherapy,
Surgery, Radiotherapy & Target Therapy.
The market dynamics section of the report elaborates the
factors that are driving the market as well as the challenges inhibiting
growth. The research study also includes insights of the key market trends, a
detailed analysis of the changing competitive landscape, and revenue forecasts
for each segment and sub-segment.
All this information is provided to assist
the established market players and new entrants in taking their strategic
decisions, thereby aiding them in strengthening their market position in a
highly competitive non-small cell lung cancer treatments market in Europe.
“Europe Non-Small Cell Lung
Cancer Treatments Market Opportunities, 2010 - 2020” report
elaborates the following aspects of non-small
cell lung cancer treatments market in Europe:
ü Europe Non-Small Cell Lung Cancer Treatments Market
Size, Share & Forecast
ü Segmental Analysis – By Target Disease, By Type, By
Region, By Company
ü Policy & Regulatory Landscape
ü Changing Market Trends & Emerging Opportunities
ü Competitive Landscape & Strategic
Should Buy This Report?
ü To identify the on-going trends and anticipated
growth in the next five years
ü To gain competitive knowledge of leading market
ü To avail 10% customization in the report without
any extra charges and get the research data or trends added in the report as
per the buyer’s specific needs
Key Questions This Study Will
ü What would be the segmental
and regional growth trends in the Europe
non-small cell lung cancer treatments market in the coming years?
ü What are the most important
growth drivers and opportunities in the market?
ü Which therapy is preferred the
ü What strategies should market
competitors employ to gain share in mature segments of the Europe non-small
cell lung cancer treatments market?
ü What are the competitor
profiles in this market and how do they compete for market share?
Report MethodologyThe information contained in this report is based upon both primary and secondary sources. Primary research included interviewswith NSCLC drug manufacturers, healthcare providers and industry experts.Secondary research included an exhaustive search of relevant publications likecompany annual reports, financial reports and proprietary databases.